Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Liver Diseases × Ribavirin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hepatitis C 4 Carcinoma, Hepatocellular 3 Respiratory Tract Infections 2 Respiratory Syncytial Virus Infections 1 Recurrence 1 Pneumonia 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Non-Hodgkin 1 Liver Neoplasms 1 Liver Diseases 1 Leukemia, Myeloid, Acute 1 Infections 1 Hepatitis 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1 Bronchiolitis Obliterans Syndrome 1

Interventions

ledipasvir, sofosbuvir drug combination 2 pevonedistat 1 belinostat 1 Sofosbuvir 1 Ribavirin 1 Ramucirumab 1 Magnetic Resonance Imaging 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02717949 2019-01-08

Optimal

University of Texas Southwestern Medical Center

Phase 4 Terminated

Hepatitis C, Liver Diseases, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡